European Healthtech startup funding raised during August 2017.
In August 2017, 29 European Healthtech companies raised a combined €1.1B across 29 funding rounds, up 2995.9% versus August 2016. Switzerland led by capital raised, and Seventure Partners was the most active investor. Data as of 23 Aug 2026.
1 exit.
| Company | Stage | Date | Amount |
|---|---|---|---|
| Roivant Sciences | Growth/Late | Aug 2017 | €938M |
| Push Doctor | Series B | Aug 2017 | €22M |
| Bioserenity | Series A | Aug 2017 | €15M |
| Blueprint Genetics | Series A |
| Aug 2017 |
| €14M |
| Magenta Medical | Series B | Aug 2017 | €13M |
| Antidote Technologies | Other | Aug 2017 | €9.4M |
| Oxford Genetics | Other | Aug 2017 | €8.1M |
| Hybrigenics | Other | Aug 2017 | €6.8M |
| LNC Therapeutics | Series C | Aug 2017 | €6.5M |
| Theranica | Other | Aug 2017 | €5.1M |
| Aifloo | Series A | Aug 2017 | €5.1M |
| Machtfit | Series A | Aug 2017 | €2.2M |
| SelfDiagnostics | Grant | Aug 2017 | €1.6M |
| Health Invest | Other | Aug 2017 | €1.3M |
| Virometrix | Series A | Aug 2017 | €1.1M |
